Holding(s) in Company
On October 15, 2025, TheraCryf PLC received notification that Northern Standard Limited crossed a threshold on October 14, 2025, regarding major holdings. Northern Standard Limited, through its shareholder Fiske Nominees Limited, now holds 20.01% of the voting rights attached to shares, representing 430,069,568 voting rights. This is an increase from their previous notification of 19.85%. The chain of control is through Dr. John Wardle, who owns 100% of Tracarta Limited, which holds 51% of Northern Standard Limited. Mr. Edward James Norman Wardle, a non-executive director of TheraCryf PLC, holds a 49% ownership interest in Northern Standard Limited but does not exercise majority control.
Select text to share a quote on X · sign in to keep highlights & notes in your TCF notes
| 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii : | TheraCryf Plc |
- Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)
UK
- Reason for the notification (please mark the appropriate box or boxes with an "X")
| An acquisition or disposal of voting rights | x |
An acquisition or disposal of financial instruments
An event changing the breakdown of voting rights
Other (please specify) iii :
Details of person subject to the notification obligation iv
| Name | Northern Standard Limited |
Full name of shareholder(s) (if different from 3.) v
| Name | Fiske Nominees Limited |
| City and country of registered office (if applicable) | 100 Wood Street, London, England, EC2V 7AN |
| 5. Date on which the threshold was crossed or reached vi : | 14/10/2025 |
| 6. Date on which issuer notified (DD/MM/YYYY): | 15/10/2025 |
- Total positions of person(s) subject to the notification obligation
| Resulting situation on the date on which threshold was crossed or reached | 20.01% | - | 20.01% | 430,069,568 |
| Position of previous notification (if applicable) | 19.85% | - | 19.85% | |
| A: Voting rights attached to shares | ||||
| Class/type of shares ISIN code (if possible) | Number of voting rights ix | % of voting rights | ||
| Direct (DTR5.1) | Indirect (DTR5.2.1) | Direct (DTR5.1) | Indirect (DTR5.2.1) | |
| GB00BSVYN304 | 430,069,568 | - | 20.01% | - |
| SUBTOTAL 8. A | 430,069,568 | 20.01% | ||
B 1: Financial Instruments according to DTR5.3.1R (1) (a)
SUBTOTAL 8. B 1
B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)
SUBTOTAL 8.B.2
| Dr John Wardle | - | - | - |
| Tracarta Limited | - | - | - |
| Northern Standard Limited | 20.01% | - | 20.01% |
In case of proxy voting, please identify:
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
- Additional information xvi
- Edward James Norman Wardle, who is a non-executive director of Theracryf, PLC holds a 49% ownership interest in Northern Standard Limited but does not exercise majority control. The chain of control is through Dr John Wardle, who owns 100% of Tracarta Limited, which holds 51% of Northern Standard Limited.
| Place of completion | St. Peter Port, Guernsey |
| Date of completion | 15/10/2025 |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.